Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 14 Feb 2024 07:00 CET |
BERGENBIO | BerGenBios resultater for fjerde kvartal 2023: Fokusert strategi gir momentum | 20103010 Biotechnology | Innsideinformasjon |
| 07 Feb 2024 12:00 CET |
BERGENBIO | BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Feb 2024 07:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to fourth quarter 2023 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Jan 2024 17:14 CET |
BERGENBIO | BerGenBio ASA – Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 15 Dec 2023 16:48 CET |
BERGENBIO | BerGenBio announces closure of EU-SolidAct bemcentinib study arm in hospitalized COVID-19 patients | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2023 07:00 CET |
BERGENBIO | BerGenBio to Present at DNB Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Dec 2023 07:00 CET |
BERGENBIO | BerGenBio Announces Final Bemcentinib Phase 2 Data in AML and MDS Presented at the 2023 ASH Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2023 18:10 CET |
BERGENBIO | BerGenBio ASA: Grant of share options | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 08 Dec 2023 08:33 CET |
BERGENBIO | BerGenBio ASA - New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 07 Dec 2023 14:05 CET |
BERGENBIO | BerGenBio ASA: Approval and publication of prospectus | 20103010 Biotechnology | Prospectus / admission document |
| 07 Dec 2023 10:47 CET |
BERGENBIO | BerGenBio ASA - Updated timeline for delivery of new shares | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Nov 2023 17:30 CET |
BERGENBIO | BerGenBio ASA - Final results for the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Nov 2023 19:00 CET |
BERGENBIO | BerGenBio ASA - Preliminary results for the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Last day of the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Siste dag av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 24 Nov 2023 13:46 CET |
BERGENBIO | BerGenBio ASA - Information about the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Nov 2023 15:23 CET |
BERGENBIO | BerGenBio ASA Mandatory notification of trade by primary insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Start av den første utøvelsesperioden for de frittstående tegningsrettene utstedt i forbindelse med fortrinnsrettsemisjonen | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 15 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio ASA - Commencement of the first exercise period for warrants issued in connection with rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio Reports Third Quarter 2023 Financial Results | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Nov 2023 19:46 CET |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Nov 2023 12:00 CET |
BERGENBIO | BerGenBio ASA: Invitation to third quarter 2023 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Nov 2023 07:00 CET |
BERGENBIO | BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 02 Nov 2023 14:00 CET |
BERGENBIO | BerGenBio Announces Poster Presentation at Upcoming ASH Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 Oct 2023 14:00 CET |
BERGENBIO | BerGenBio Announces Poster Presentation at Upcoming SITC Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Oct 2023 07:30 CEST |
BERGENBIO | New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Oct 2023 07:00 CEST |
BERGENBIO | Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Sep 2023 07:00 CEST |
BERGENBIO | BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Aug 2023 20:35 CEST |
BERGENBIO | Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 23 Aug 2023 07:00 CEST |
BERGENBIO | BerGenBio Reports Second Quarter 2023 Financial Results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 22 Aug 2023 10:30 CEST |
BERGENBIO | BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Aug 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Jun 2023 14:39 CEST |
BERGENBIO | BerGenBio ASA: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 27 Jun 2023 13:10 CEST |
BERGENBIO | BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Information about the Warrants issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 12:36 CEST |
BERGENBIO | BerGenBio ASA - Correction, new share capital and warrants registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 22 Jun 2023 11:36 CEST |
BERGENBIO | BerGenBio ASA - New share capital and warrants registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 22 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jun 2023 16:40 CEST |
BERGENBIO | BerGenBio ASA - Updated timeline for delivery of Offer Shares and Warrants in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Jun 2023 08:10 CEST |
BERGENBIO | BerGenBio ASA - Mandatory notification of trade, allocations to primary insiders and close associates in the Rights Issue | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 14 Jun 2023 17:21 CEST |
BERGENBIO | BergenBio ASA - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 14 Jun 2023 16:48 CEST |
BERGENBIO | BerGenBio - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 14 Jun 2023 15:20 CEST |
BERGENBIO | BerGenBio ASA - Correction of final results of the Rights Issue | 20103010 Biotechnology | Inside information |
| 14 Jun 2023 13:30 CEST |
BERGENBIO | BerGenBio ASA - Final results of the Rights Issue | 20103010 Biotechnology | Inside information |
| 13 Jun 2023 20:30 CEST |
BERGENBIO | BerGenBio ASA - Preliminary results indicates an oversubscribed Rights Issue of gross NOK 250 million | 20103010 Biotechnology | Inside information |
| 13 Jun 2023 09:49 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Last day of the Subscription Period in the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jun 2023 22:01 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Jun 2023 17:20 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Last day of trading in Subscription Rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |